NVS

What one share of Novartis AG holds

Pharmaceutical Preparations

Novartis AG’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.

Per-share figures
Profit$7.15
Capex (buildings and equipment)$0.79
Free cash flow$9.00
Dividends$4.00
Cash and investments$5.99
Debt$15.06
Book value$24.18

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2016—$2.80$0.78$4.01—$31.55
2017—$3.25$0.56$4.76—$32.00
2018—$5.38$0.54$5.55—$34.01
2019—$5.06$0.59$5.28—$24.49
2020—$3.52$0.56$5.39—$25.08
2021—$10.63$0.47$6.20—$30.27
2022—$3.17$0.42$6.06—$28.00
2023—$7.10$0.51$6.40—$22.83
2024—$5.87$0.67$7.99—$22.30
2025—$7.15$0.79$9.00—$24.18

Common questions about Novartis AG

How much does one share of Novartis AG earn?

Over its latest fiscal year, each share of Novartis AG earned $7.15 of profit.

Does Novartis AG pay a dividend?

Yes. Novartis AG paid $4.00 per share in dividends over its latest fiscal year. That’s about 56¢ of each $1 of profit (payout ratio).

What is Novartis AG’s book value per share?

Novartis AG’s book value is $24.18 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.

How much cash and debt does each share of Novartis AG have?

Each share of Novartis AG has $5.99 of cash and investments and $15.06 of debt, as of December 31, 2025.

What is Novartis AG’s free cash flow per share?

$9.00 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

How has Novartis AG’s profit per share changed over time?

Profit per share went from $2.80 in 2016 to $7.15 in 2025, growing about 11.0% a year (adjusted for stock splits).

Has Novartis AG bought back shares?

Novartis AG’s share count fell about 19% from 2016 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.